(Source: Applied Clinical Trials, 2026) Weight Loss Progress Over Time STEP-1 Trial Related at GoalBMI Wellness Semaglutide & Cardiovascular Health SELECT Trial Data Beyond weight loss, the 2023 SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) trial established semaglutide as a cardiovascular medication a landmark finding that expanded its clinical use far beyond obesity treatment
For researchers who use pharmaceutical GLP-1 therapies as their primary intervention, many of these supplements serve as useful adjuncts
The first experiments demonstrating effects of peripheral GLP-1 in humans were published by Flint et al
However, with ghee rich in linoleic acid, demonstrated a reduction in prostaglandins, leucotrines and interleukins associated with inflammation
Resveratrol, is a plant flavonoid, which offers antioxidant protection, and rosemary brings centuries of traditional use for its supportive properties